. . . . "The ability to induce autologous adult mesenchymal stem cells into MSC-NTF cells makes NurOwn??? technology highly attractive for treating neurodegenerative diseases such as ALS and PD as well as MS and spinal cord injury.As far as I see, today there is an overlap between research and treatment, just like in the case of Celltex, when a certain technology is in clinical trials, but in some place t" .